Literature DB >> 27318134

Metabolic changes over the course of aging in a mouse model of tau deposition.

Aurélie Joly-Amado1, Karisa S Serraneau2, Milene Brownlow2, Caralina Marín de Evsikova3, John R Speakman4, Marcia N Gordon2, Dave Morgan2.   

Abstract

Weight loss and food intake disturbances that often precede cognitive decline and diagnosis have been extensively reported in Alzheimer's disease patients. Previously, we observed that transgenic mice overexpressing tau seemed to eat more food yet weigh less than nontransgenic littermates. Thus, the present longitudinal study measured the time course of changes in metabolic state over the lifespan of the tau depositing Tg4510 mouse model of tau deposition. Although body weight was comparable to nontransgenic littermates at 2 months of age, Tg4510 mice weighed less at older ages. This was accompanied by the accumulation of tau pathology and by dramatically increased activity in all phases of the 24-hour cycle. Resting metabolic rate was also increased at 7 months of age. At 12 months near the end of the Tg4510 lifespan, there was a wasting phase, with a considerable decrease of resting metabolic rate, although hyperactivity was maintained. These diverse changes in metabolism in a mouse model of tau deposition are discussed in the context of known changes in energy metabolism in Alzheimer's disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Basal metabolic rate; Body weight gain; Energy expenditure; Food intake; Locomotor activity; Metabolism; Mice; Tau protein; Tauopathy; Tg4510; Transgenic

Mesh:

Substances:

Year:  2016        PMID: 27318134      PMCID: PMC4913041          DOI: 10.1016/j.neurobiolaging.2016.04.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  70 in total

1.  Limits to sustained energy intake. X. Effects of fur removal on reproductive performance in laboratory mice.

Authors:  Elzbieta Król; Michelle Murphy; John R Speakman
Journal:  J Exp Biol       Date:  2007-12       Impact factor: 3.312

2.  Localization of a "feeding center" in the hypothalamus of the rat.

Authors:  B K ANAND; J R BROBECK
Journal:  Proc Soc Exp Biol Med       Date:  1951-06

3.  Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease.

Authors:  Elysse M Knight; Alexei Verkhratsky; Simon M Luckman; Stuart M Allan; Catherine B Lawrence
Journal:  Neurobiol Aging       Date:  2010-03-31       Impact factor: 4.673

4.  Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.

Authors:  Pia Jul; Christiane Volbracht; Inge E M de Jong; Lone Helboe; Anders Brandt Elvang; Jan Torleif Pedersen
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

5.  A guide to analysis of mouse energy metabolism.

Authors:  Matthias H Tschöp; John R Speakman; Jonathan R S Arch; Johan Auwerx; Jens C Brüning; Lawrence Chan; Robert H Eckel; Robert V Farese; Jose E Galgani; Catherine Hambly; Mark A Herman; Tamas L Horvath; Barbara B Kahn; Sara C Kozma; Eleftheria Maratos-Flier; Timo D Müller; Heike Münzberg; Paul T Pfluger; Leona Plum; Marc L Reitman; Kamal Rahmouni; Gerald I Shulman; George Thomas; C Ronald Kahn; Eric Ravussin
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

6.  Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up.

Authors:  S Andrieu; W Reynish; F Nourhashemi; P J Ousset; H Grandjean; A Grand; J L Albarede; B Vellas
Journal:  J Nutr Health Aging       Date:  2001       Impact factor: 4.075

7.  Distinct behavioural profiles in frontotemporal dementia and semantic dementia.

Authors:  J S Snowden; D Bathgate; A Varma; A Blackshaw; Z C Gibbons; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

Review 8.  IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease.

Authors:  S Gillette Guyonnet; G Abellan Van Kan; E Alix; S Andrieu; J Belmin; G Berrut; M Bonnefoy; P Brocker; T Constans; M Ferry; A Ghisolfi-Marque; L Girard; R Gonthier; O Guerin; M-P Hervy; P Jouanny; M-C Laurain; L Lechowski; F Nourhashemi; A Raynaud-Simon; P Ritz; J Roche; Y Rolland; T Salva; B Vellas
Journal:  J Nutr Health Aging       Date:  2007 Jan-Feb       Impact factor: 4.075

9.  A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.

Authors:  Shirley W Tsang; Janet Keene; Tony Hope; Ian Spence; Paul T Francis; Peter T-H Wong; Christopher P Chen; Mitchell K Lai
Journal:  J Neurol Sci       Date:  2009-10-08       Impact factor: 3.181

10.  Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.

Authors:  Antoine Leboucher; Cyril Laurent; Francisco-José Fernandez-Gomez; Sylvie Burnouf; Laetitia Troquier; Sabiha Eddarkaoui; Dominique Demeyer; Raphaëlle Caillierez; Nadège Zommer; Emmanuelle Vallez; Kadiombo Bantubungi; Christophe Breton; Pascal Pigny; Valérie Buée-Scherrer; Bart Staels; Malika Hamdane; Anne Tailleux; Luc Buée; David Blum
Journal:  Diabetes       Date:  2012-12-18       Impact factor: 9.461

View more
  11 in total

1.  Adenylyl cyclase 6 is required for maintaining acid-base homeostasis.

Authors:  Søren Brandt Poulsen; Caralina Marin De Evsikova; Sathish Kumar Murali; Jeppe Praetorius; Yijuang Chern; Robert A Fenton; Timo Rieg
Journal:  Clin Sci (Lond)       Date:  2018-08-30       Impact factor: 6.124

Review 2.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

Review 3.  Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.

Authors:  Fang Xie; Fangyu Peng
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology.

Authors:  A Joly-Amado; H Davtyan; K Serraneau; P Jules; A Zitnyar; E Pressman; K Zagorski; T Antonyan; A Hovakimyan; H J Paek; M N Gordon; D H Cribbs; N Petrovsky; M G Agadjanyan; A Ghochikyan; D Morgan
Journal:  Neurobiol Dis       Date:  2019-10-17       Impact factor: 5.996

Review 5.  Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.

Authors:  Kai Ma; Nian Xiong; Yan Shen; Chao Han; Ling Liu; Guoxin Zhang; Luxi Wang; Shiyi Guo; Xingfang Guo; Yun Xia; Fang Wan; Jinsha Huang; Zhicheng Lin; Tao Wang
Journal:  Front Aging Neurosci       Date:  2018-01-19       Impact factor: 5.750

6.  Oligomeric tau-targeted immunotherapy in Tg4510 mice.

Authors:  Sulana Schroeder; Aurelie Joly-Amado; Ahlam Soliman; Urmi Sengupta; Rakiz Kayed; Marcia N Gordon; David Morgan
Journal:  Alzheimers Res Ther       Date:  2017-06-27       Impact factor: 6.982

7.  Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.

Authors:  C M Holton; N Hanley; E Shanks; P Oxley; A McCarthy; B J Eastwood; T K Murray; A Nickerson; K A Wafford
Journal:  Alzheimers Res Ther       Date:  2020-07-15       Impact factor: 6.982

8.  CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model.

Authors:  Dylan J Finneran; Dave Morgan; Marcia N Gordon; Kevin R Nash
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-29       Impact factor: 4.147

9.  A Mutant Variant of E2F4 Triggers Multifactorial Therapeutic Effects in 5xFAD Mice.

Authors:  Noelia López-Sánchez; Morgan Ramón-Landreau; Cristina Trujillo; Alberto Garrido-García; José M Frade
Journal:  Mol Neurobiol       Date:  2022-03-07       Impact factor: 5.682

10.  A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.

Authors:  Antonio J López-Gambero; Cristina Rosell-Valle; Dina Medina-Vera; Juan Antonio Navarro; Antonio Vargas; Patricia Rivera; Carlos Sanjuan; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.